This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.
Age range
7 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Soleus Muscle Activity
Timeframe: Change from baseline to intervention follow-up, assessed up to 18 months
Change in Peak Ankle Power
Timeframe: Change from baseline to intervention follow-up, assessed up to 18 months
Change in Self-Selected Walking Speed
Timeframe: Change from baseline after intervention.
Change in Dynamic Motor Control During Walking (Walk-DMC)
Timeframe: Change from baseline to intervention follow-up, assessed up to 18 months
Change in Gait Deviation Index (GDI)
Timeframe: Change from baseline to intervention follow-up, assessed up to 18 months
Change in Gross Motor Function Measure - 66 (GMFM-66) Parts D & E
Timeframe: Change from baseline to intervention follow-up, assessed up to 18 months